Sebastian Meyer
Chief Operating Officer
Numab Innovations
Switzerland
Biography
Sebastian joined Numab in 2012 and is responsible for the engineering, manufacturing process development and biophysical characterization of the company’s antibody-based therapeutics. Before joining Numab, Sebastian headed the downstream processing and analytics unit of ESBATech, focusing on process development and characterization of novel scFv drug candidates in Phase I/II of clinical development. Prior to that, Sebastian was a bioprocess development group leader at Cytos Biotechnology. During his post-graduate studies, Sebastian investigated the structure and function of chloride channels and transporters. Sebastian graduated with a degree in Biochemistry from the University of Hamburg and obtained his PhD from the University of Zurich.
Research Interest
Biochemistry
